Argon plasma treatment versus monitoring for moderate cervical precancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial compares two ways of managing CIN 2, a moderate precancerous change on the cervix. One option is a new procedure that uses argon plasma (a type of energized gas) to treat the area; the other is careful monitoring without immediate treatment, to see if one works better at clearing the abnormal cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman aged 18 to 40.
- You have a biopsy showing CIN 2 (a moderate precancerous change on the cervix).
- Your doctor must be able to see the whole affected area clearly during a special exam called colposcopy.
- You are not pregnant and do not plan to become pregnant for at least 6 months.
- You have no other serious health conditions (like severe heart disease, immune problems, or cancer) or an active severe infection.
- You are not taking part in any other clinical study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a light-activated therapy (called HAL-PDT) for a specific type of abnormal cervical cell change known as CIN2. It aims to see if this treatment can destroy the abnormal cells while keeping the cervix healthy, potentially avoiding surgery.
This study looks at how shared decision-making affects women's choices when they have abnormal cervical cells that may need treatment. It may help you feel more involved in choosing the right treatment for you.
This study tests a new tool called PreCursor-M+® to see how well it helps doctors manage CIN2, a moderate cervical cell change. It’s for people who have already been diagnosed with CIN2 and know their HPV test results.
This study tests a new non-invasive plasma treatment for cervical infections caused by high- and low-risk HPV types. It may help clear the virus and prevent related health issues.
This trial checks whether “therapy abstention” (not treating right away) and close monitoring is safe for certain high-grade cervical cell changes. It may help some people avoid immediate procedures while still catching any progression early.
This study tests a light-based treatment called photodynamic therapy for cervical pre-cancer (CIN2). It may help remove abnormal cells while avoiding more invasive surgery, and aims to see if this treatment is safe and works well.
Hear when a new CIN2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.